Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Blood Plasma Derivatives Market to Reach USD 47.85 Billion by 2032 with a CAGR of 6.77%

globenewswire.com
EBS Emergent BioSolutions Inc. is mentioned as a company profiled in a market research report on blood plasma derivatives. The article does not provide specific sentiment towards the company itself, only its inclusion in the report. GRFS Grifols, S.A. is listed as a company profiled in a report about the blood plasma derivatives market. The article does not offer any specific positive or negative sentiment regarding Grifols' performance or prospects. TAK Takeda Pharmaceutical Company Limited is named as one of the companies profiled in the blood plasma derivatives market report. The article provides no specific sentiment or analysis related to Takeda.

Dublin, Jan. 23, 2026 (GLOBE NEWSWIRE) -- The "Blood Plasma Derivatives Market - Global Forecast 2026-2032" has been added to ResearchAndMarkets.com's offering.

Blood plasma derivatives are essential to modern medical therapies, playing a crucial role across hematology, immunology, and critical care treatments. This market research report offers stakeholders insights into navigating regulatory expectations and recombinant technology advancements, vital for ensuring operational excellence and fostering innovation.

Market Snapshot: Blood Plasma Derivatives Market Size and Growth

The Blood Plasma Derivatives Market demonstrates substantial growth, expanding from USD 30.24 billion in 2025 to USD 32.15 billion in 2026, with an anticipated CAGR of 6.77%, projected to reach USD 47.85 billion by 2032.

Scope & Segmentation

Key Takeaways from This Report

Key Attributes:

Companies Profiled in the Report

Bharat Serums and Vaccines Limited

Bio Products Laboratory Limited (BPL)

Biotest AG

China Biologic Products Holdings, Inc.

CSL Behring GmbH

Emergent BioSolutions Inc.

Grifols, S.A.

Hualan Biological Engineering Inc.

Intas Pharmaceuticals Ltd.

Kamada Ltd.

Kedrion S.p.A.

LFB S.A.

Octapharma AG

Reliance Life Sciences Pvt. Ltd.

Sanquin Plasma Products B.V.

Shanghai RAAS Blood Products Co., Ltd.

Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.

SK Plasma Co., Ltd.

Takeda Pharmaceutical Company Limited

For more information about this report visit https://www.researchandmarkets.com/r/6esg04

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment